A Landscape Analysis of Oncolytic Viruses

Time: 2:15 pm
day: Day Two


  • An overview of the current oncolytic virotherapy drug and trial landscapes
  • Trends within the space, including genetic modifications and combination approaches
  • An analysis of the preclinical landscape, and what it can tell us about the potential future of OVs